Pyrosoft Health Inc.

PyroSoft Health Inc. is a research and development (R&D) company established under the leadership of Dr. Mustafa Küçükali, President of the Organ, Tissue, and Cell Transplantation Association, bringing together scientists from both domestic and international backgrounds.

This dynamic and innovative company aims to find effective and sustainable solutions to the health challenges faced by our country and the world. To achieve this goal, PyroSoft Health Inc. is extensively working on a wide range of health products and services.

This range primarily focuses on stem cell production and treatment methods while also developing solutions for serious and widespread health issues such as cancer, Covid-19, and autoimmune diseases. In addition to these health challenges, the company is actively engaged in producing cosmetic and beauty products, dietary supplements, and other healthcare products aimed at improving overall health and well-being.

PyroSoft Health Inc. conducts its R&D activities with the support and scientific consultancy of the Scientific Committee of the Organ, Tissue, and Cell Transplantation Association. This collaboration enables the company to closely follow current scientific developments and develop new and innovative solutions.

Thus, PyroSoft Health Inc. plays a significant role in the healthcare sector by developing effective solutions and enhancing the quality of life.

SCIENCE BOARD

Dr Pinar Uysal-Onganer is Reader in Molecular Biology and Group Leader of the Cancer Mechanisms and Biomarkers Research Group at the University of Westminster. She is also Adjunct Professor and Faculty Board Member at Oklahoma State University. With more than two decades of translational cancer research experience, her work focuses on non-coding RNAs as drivers and biomarkers of cancer progression, particularly in pancreatic and prostate cancer.

Dr Uysal-Onganer has published extensively on microRNAs, cellular signalling, and cancer metastasis, contributing to both fundamental biology and the development of translational tools such as liquid biopsies and diagnostic assays.

Committed to education and equality, she leads the MSc Precision Medicine module and Cancer Mechanisms and Biomarkers Research Group at University of Westminster, integrates research into student training, and actively promotes women and underrepresented groups in science. She also serves on the editorial boards of several international journals.